Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Opsoclonus-Ataxia Syndrome in a Patient With Small-Cell Lung Cancer Treated With Immune Checkpoint Inhibitors

16 Jul 2024

Abstract excerpt

OBJECTIVES: To describe a case of post-immune checkpoint inhibitor (ICI) opsoclonus-myoclonus-ataxia syndrome (OMAS), with complete clinical remission after treatment. METHODS: A 52-year-old man was admitted because of subacute-onset vertigo, dysarthria, vomiting, and weight loss. He was under atezolizumab (anti-PD-L1) monotherapy (23 cycles) for metastatic small-cell lung cancer, with excellent response....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Autoimmune Neurological Disorders and Treatments
Share to Brain Metastases and Treatment
Share to Cancer Immunotherapy and Biomarkers

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 39013128
DOI: 10.1212/nxi.0000000000200287

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Opsoclonus-Ataxia Syndrome in a Patient With Small-Cell Lung Cancer Treated With Immune Checkpoint InhibitorsPMID 39013128Read ↗

Neuroblastoma presenting as opsoclonus-myoclonus: A series of six cases and review of literatureSemantic proximity Read ↗

Anti- SOX1 antibody-positive paraneoplastic neurological syndrome presenting with Lambert–Eaton myasthenic syndrome and small cell lung cancer: a case reportSemantic proximity Read ↗

Breast Cancer Associated Opsoclonus-Myoclonus Syndrome: A Case ReportSemantic proximity Read ↗

Opsoclonus Myoclonus Ataxia Syndrome in the Setting of COVID-19 InfectionSemantic proximity Read ↗

Update on Pediatric Opsoclonus Myoclonus SyndromeSemantic proximity Read ↗

Spectrum of Movement Disorders in Hematological Malignancies: A Comprehensive Systematic Review of Clinical Phenotypes, Mechanisms, and Outcomes.Semantic proximity Read ↗

Oculomotor phenotypes and longitudinal video-oculography dynamics in anti-GAD65 antibody-associated neurological syndromes: a case series and literature review.Semantic proximity Read ↗

Cerebellar Ataxia as the Initial Manifestation of Anti-NMDAR Encephalitis Without Prodrome: A Case reportSemantic proximity Read ↗

Revisiting anti-Hu paraneoplastic autoimmunity: phenotypic characterization and cancer diagnosisSemantic proximity Read ↗

Atezolizumab- and bevacizumab -induced encephalitis in a patient with advanced hepatocellular carcinoma: a case report and literature reviewSemantic proximity Read ↗

Vemurafenib as first-line therapy in BRAF-V600E-mutant Erdheim-Chester disease with CNS involvement.Semantic proximity Read ↗

An update on opsoclonusSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.